{"id":"lucimycin","rwe":[],"tags":[{"label":"lucimycin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Anti-Bacterial Agents","category":"pharmacology"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Antifungal Agents","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"lucimicina","offLabel":[],"synonyms":["lucensomycin","etruscomycin","leucensomycin","lucimycin","lucimycine","lucimicina"],"timeline":[],"approvals":[],"brandName":"Lucimicina","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"lucimycin","explanation":"Imagine your body's cells are like locks, and Lucimicina is a key that fits into one of those locks. When it binds, it can either turn the lock on or off, depending on the type of lock and the key's shape. This can help control the activity of certain cellular processes.","oneSentence":"Lucimicina works by binding to a specific target, but its target is currently unknown.","technicalDetail":"Lucimicina's mechanism of action is not well understood, but it is believed to involve binding to a specific protein or receptor, potentially altering downstream signaling pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3329","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LUCIMYCIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:00:30.684077","biosimilars":[],"competitors":[],"genericName":"lucimycin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"3K1B4B63D0","CHEBI":"CHEBI:135874","INN_ID":"1360","UMLSCUI":"C0024072","ChEMBL_ID":"CHEMBL3989598","PUBCHEM_CID":"118984381","MESH_DESCRIPTOR_UI":"D008155"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":5,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lucimicina (LUCIMYCIN) is a small molecule drug in the lucimycin class, but its target and mechanism of action are unknown. Its commercial status and approved indications are also unclear. As a result, key safety considerations and pharmacokinetic properties such as half-life and bioavailability are not well established. Further research is needed to fully understand this drug. Its ownership and patent status are also unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}